IFNA1 and viral infectious disease: A robust antiviral response is primarily dependent on the IFN response, and the mechanisms through which SARS-CoV-2 and its variants inhibit the IFN signaling pathways (IFN-I/IFN-III) along with the regulation of the ISG expression in favor of viral infection [10,36,39].